New vaccines based on RNA replicons against viruses such as MERS-CoV and SARS-CoV-2

Two different vaccines prototypes have been developed based on RNA replicons from SARS-CoV-2 and MERS-CoV, encapsulated in Virus-Like Particles (VLPs…

Vacuna para la prevención de la anaplasmosis

Vacuna basada en un antígeno quimérico recombinante que puede ser usado para la prevención o el tratamiento de infecciones causadas por Anaplasma…

Vaccine for the prevention of anaplasmosis

Recombinant chimeric antigen used for the prevention or treatment of infections caused by Anaplasma phagocytophilum.